Skin cancer can strike anyone. Approximately 4% of all cancer patients in Austria suffer from skin melanoma and the earlier it can be detected, the better the chances are of survival. The 14th installment of the JKU medTALK series focused the topic of skin cancer: A new 3D imaging system and an AI-supported initial analysis can assess a patient's risk in just five minutes.

At the podium:

• Univ. Prof. Dr. Wolfram Hötzenecker, head of the Department of Dermatology and Venereology, JKU 
• Univ. Prof. Dr. Emmanuella Guenova, head of the Clinical Department of Translational Immunodermatology, JKU
• Univ. Prof. Dr. Rupert Langer, head of the Clinical Institute of Pathology and Molecular Pathology, JKU
• Assist. Dr. Viktoria Puxkandl, Department of Dermatology and Venereology, JKU

Moderator: Dr. Christine Haiden, journalist and President of the Upper Austrian Press Club

Click here, opens an external URL in a new window to watch the 14^th installment of the JKU medTALK series.

The JKU’s medTALK series at the medLOFT (JKU MED Campus) focuses on the future of medicine ranging from recent research findings and healthcare, to patient care.

The JKU aims to create a platform six times a year to not only explore research and innovation in medicine, but also give physicians and media and medical industry experts an opportunity to discuss controversial topics. The JKU medTALK series is open to the public.